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Polyphenols are a group of chemical substances found in plants, with immunomodulatory, antiproliferative, and anti-
inflammatory properties that might be useful in the prophylaxis and treatment of graft-versus-host disease (GVHD).
Polyphenolic extract (PE) obtained from extra virgin olive oil (EVOO) decreased the activation and proliferation of acti-
vated T cells. In addition, a decreased production of proinflammatory cytokines was observed upon exposure to PE.
Western blot assays showed a marked inhibition of Akt phosphorylation and nuclear translocation of NF-kB in activated
T cells. In amurinemodel of acute GVHD, we observed thatmice that received a diet supplemented in PE (600 ppm) pre-
sented a higher survival rate and lower risk of developing GVHDwhen compared with the group that received a control
diet. Histopathologic examination showed a significantly lower gut involvement in mice receiving PE, with a decrease in
proinflammatory cytokines (IL-2, IL-17, and TNF-a) in serum and the reestablishment of butyrate concentration in the
gut. In conclusion, PE obtained from EVOO exerted a potent immunomodulatory effect, reducing the activation and
proliferation of activated T cells and the production of proinflammatory cytokines. In a murine model of acute GVHD, a
PE-supplemented diet reduced the incidence and severity of the disease and increased survival after transplantation.
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for Transplantation and Cellular Therapy. Published by Elsevier Inc.INTRODUCTION
Graft-versus-host disease (GVHD) is one of the most common
complications after allogeneic hematopoietic stem cell transplan-
tation (allo-HSCT) [1]. It remains a significant cause of treatment
failure, resulting in a mortality of >20% and a morbidity of >50%
in transplant recipients [2]. Acute GVHD (aGVHD) is mediated by
alloreactive immunocompetent donor T cells as well as the deliv-
ery of proinflammatory cytokines that induce damage in target
organs such as skin, liver, or gastrointestinal tract [3,4].
Polyphenols are a group of chemical substances found in
plants that are characterized by the presence of more than 1phenol unit with 1 or more hydroxyl group [5]. The polyphenols
can be obtained from grains, legumes, fruits, vegetables, extra
virgin olive oil (EVOO), red wine, and tea [6]. These substances
exercise their effect on T cells through different pathways related
to cell proliferation, differentiation, and/or activation [7,8].
Specifically, polyphenols can favor regulatory T cell functions,
decrease IFN-g production by stimulated T cells [9,10], and pre-
vent autoimmunity and allergy [11,12]. Interestingly, a green tea
polyphenol, epigallocatechin-3-gallate (EGCG), has been found to
protect from allograft rejection and attenuates GVHD [13].
EVOO is a source of phenolic compounds such as glycoside
oleuropein, hydroxytyrosol, and tyrosol. Olive oil polyphenolic
extracts (PEs) have antioxidant, immunomodulatory, antiproli-
ferative, and anti-inflammatory effects [14-16].
In the current study, we have evaluated the effect of PEs
obtained from olive oil on T cell activation in vitro and the
potential utility of a diet enriched in PEs in aGVHD prophylaxis
in a murine model. We confirmed that PE reduces T cell activa-
tion, proliferation, and proinflammatory cytokine secretion in
vitro. Finally, we also confirmed in a murine model of aGVHD
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ity of the disease and increased survival after transplantation.
METHODS
Human Samples
Peripheral bloodmononuclear cells (PBMCs) were isolated from buffy coats
of healthy volunteer donors. All samples were obtained from the regional cen-
ter of blood donation of the University Hospital Virgen del Rocío (Seville, Spain).
The local ethics committee provided institutional review board approval for
this study, and informed consent was obtained from all donors, by the Declara-
tion of Helsinki. PBMCs from buffy coats were isolated by density gradient cen-
trifugation using a Ficoll Paque solution (Biosciences, Uppsala, Sweden).
Extraction PE and Characterization of Phenolic Compounds
PE was obtained by the method described by Vazquez Roncero et al. [17]
(Supplementary Methods). The methanolic extract was concentrated in vac-
uum under a stream of nitrogen at<35°C until it reached a syrup consistency.
Finally, it was lyophilized and stored at 80°C.
Proliferation and Viability Assays
For the proliferation assays, 2 £ 105 PBMCs stained with the green fluo-
rescent dye PKH-67 (Sigma-Aldrich, Saint Louis, MO, United States) were
seeded in 96-well plates (Biofil, China) at a density of 2 £ 105 cells/well in
RPMI 1640 medium supplemented with 100 U/mL penicillin, 100 mg/mL
streptomycin (all reagents were purchased from Gibco-Invitrogen, Paisley,
UK), and 10% human AB serum (Sigma-Aldrich) under different culture con-
ditions: in the absence of stimulus or stimulated with plate-bound anti-CD3
(5 mg/mL) and soluble anti-CD28 (2.5 mg/mL) monoclonal antibodies (mAbs)
(BD Biosciences, San Jose, CA). Different concentrations (0, 10, 45, and 60 mg/mL)
of PE were added to each culture condition. After 18 hours, the cells were
collected; stained with CD25-FITC, CD4-APC-H7, CD8-PE-Cy7, CD-64-PE,
7-amino-actinomycin D (7AAD), and anti-CD3-APC mAbs; and acquired in a
FACSCanto II flow cytometer (BD Biosciences) using a FACS Diva software
program (BD Biosciences). The ModFit programwas used to calculate the per-
centage of resting (PKHhighCD25) and proliferating cells.
For cell viability, cell cultures were managed as previously described.
After 18 hours, unstimulated or stimulated cells were collected and stained
with anti-CD25-FITC, anti-CD3-APC mAbs, 7AAD, and Annexin V-PE using the
PE Annexin V Apoptosis Detection Kit (BD Pharmingen, San Jose, CA) accord-
ing to manufacturer`s instructions. For every condition, 50,000 events were
acquired on a FACSCanto flow cytometer (BD Biosciences) using the CellQuest
software program, and the percentage of Annexin V-PE cells was calculated
using the Infinicyt software (Cytognos, Salamanca, Spain).
Cytokine Assays
After 48 hours, with the same culture conditions previously described,
supernatants were collected to calculate the concentration of different
cytokines (IL-2, IL-4, IL-6, IL-10, TNF-a, and IFN-g) by flow cytometry. For that
purpose, we used the BD Human Th1/Th2 Cytokine Cytometric Bead Array kit
(BD Biosciences) according tomanufacturer’s instruction, and the samples were
analyzed using the BD Cytometric Bead Array software (BD Biosciences).
Western Blot Assays
The PBMCs were cultured as previously described with different concen-
trations (0, 10, 45, 60 mg/mL) of PE. After 18 hours of culture, cells were
lysed for protein preparation and were separated by electrophoresis on
sodium dodecyl sulfate-polyacrylamide gels and electroblotted onto PVDF
membranes. Blots were immunoblotted with antibodies against phosphory-
lated Akt (-T308) (Cell Signaling Technology, Danvers, MA), NF-kB p65 (Cell
Signaling Technology), YY1 (Abcam, Cambridge, UK), and b-actin (Abcam).
The membranes were then washed with Tween-Tris-buffered saline and
incubated with either an horseradish peroxidase (HRP)-conjugated donkey
anti-rabbit IgG antibody (Jackson ImmunoResearch, Cambridge House, UK)
or HRP-conjugated donkey anti-mouse IgG antibody (Jackson ImmunoRe-
search). Antibody detection was performed with an enhanced chemilumines-
cence reaction (Santa Cruz Biotechnology, Dallas, Texas USA).
For separation and extraction of cytoplasmic and nuclear soluble pro-
teins, we used the Subcellular Protein Fractionation Kit for Cultured Cells
(Thermo Scientific, Massachusetts, US).
Graft-versus-Leukemia Assays
T cells were purified from the spleen of BALB/C and C57BL/6 mice by
immunomagnetic depletion of non-T cells using the Pan T Cell Isolation Kit
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufac-
turer’s instructions. The purity of isolated populations was routinely >95%.
Cocultures between isolated T cells with target cells, murine leukemic cells
A20 (ATCC TIB-208), and C1498 (ATCC TIB-49) were performed at 3:1 and 5:1
ratio in a 96-well plate. The coculture was incubated at 37°C without shaking.
The cell cultures were analyzed after 24 hours by flow cytometry to study thepercentage of apoptosis using the following panel: Annexin V/7AAD, CD3-APC,
CD4-V400, CD8-V421, and CD45-APC-H7 (BD Biosciences).
To study the effect of PE in lymphocyte cytotoxic activity, splenocytes
from BALB/C and C57BL/6 mice were cultured (1 £ 106) with or without
activation (CD3/CD28) in a 48-well plate with different concentrations of PE
(0, 10, 45, and 60 mg). After 48 hours, the cells were recovered, washed,
counted, and cocultured with C1498 and A20 (murine leukemic cells) (1:5) in a
96-well plate for 24 hours. Afterward, the cells were recovered and analyzed by
flow cytometry for the percentage of viable cells (Annexin/7ADD BD kit).
Acute GVHD Murine Model
BALB/c (H2d) and C57BL/6 (H2b) mice were purchased from Charles River
Laboratory (St. Germain sur l'Arbresle, France). Animals between 8 and 12
weeks of age were housed in microisolator cages andmaintained under specific
pathogen-free conditions in the animal facility of the Institute of Biomedicine of
Seville, Spain. All procedures were used following the Spanish and European
Union guidelines and after approval of the local bioethics committee.
BALB/c mice received total body irradiation (850 cGy divided into 2 frac-
tions, from a Cs137 source) that was followed by an intravenous injection of
5 £ 106 C57BL/6 bone marrow (BM) cells with 5 £ 106 splenocytes. Mice
were monitored and weighed twice a week.
Mice were randomized into 5 experimental groups during all experimental
periods. The mice that underwent transplantation with BM and splenocytes
(aGVHD) were divided into 2 groups: (A) received a standard diet (2014S
Harlan Laboratories, Indianapolis, IN)—GVHD control diet and (B) received a
standard diet (2014S Harlan Laboratories) supplemented with 600 ppm PE
obtained from the EVOO GVHD PE diet. Control mice were also included in the
study: the group that underwent transplantation with BM from C57BL/6 and
received control diet and the group that underwent transplantation with BM
from C57BL/6 and received the PE diet. The total body irradiation group was
also included, with mice receiving irradiation without stem cell support.
The diet started from day 5 to day +100 post-transplantation. The
severity of GVHD was assessed by the percentage of weight change, a param-
eter that has been found to be a reliable indicator of systemic GVHD in this
and several other murine models.
A threshold of 10% weight loss was used to signify the presence of mod-
erate GVHD. Also, the degree of systemic GVHD was assessed by a scoring
system described by Cooke et al. [18] that incorporates 5 clinical parameters:
weight loss, posture (hunching), activity, fur texture, and skin integrity.
After day +5 and +21 post-transplantation, aGVHD was assessed by histo-
pathologic analysis of the small and large bowels and skin. Tissues were fixed
in 4% neutral-buffered formalin, embedded in paraffin, cut into 5-mm-thick
sections, and stained with hematoxylin and eosin (Merck KGaA, Darmstadt,
Germany). For immunofluorescence experiments, the tissues were labeled with
anti-CD3 (RD Systems), anti-IFN-g (ab9657; Abcam), and anti-Ki67 (ab15580;
Abcam). Slides were mounted using Vectashield H-1000 medium (Vector Labs,
Peterborough, United Kingdom). Images were visualized with an Olympus
BX-61 light microscope (Olympus Optical, Tokyo, Japan). Captured images were
handled using Adobe Photoshop CS6 (Adobe Systems, San Jose, CA).
Histopathologic analysis of small and large bowels and skin was also con-
ducted to further evaluate aGVHD. The slides were examined by a pathologist in
a blinded fashion using a severity scale [19,20]. The severity scale ranged from
0 to 4: 0, normal; 0.5, focal and rare; 1, focal andmild; 2, diffuse and mild; 3, dif-
fuse andmoderate; and 4, diffuse and severe. Changes in the colon (crypt regen-
eration, crypt epithelial cell apoptosis, crypt loss, surface colonocyte attenuation,
lamina propria inflammatory cell infiltrate, mucosal ulceration, and thickness of
the mucosa) and skin (epidermal/dermal lymphocytic infiltrate, dyskeratotic
epidermal keratinocytes and epidermal thickening) were analysed and scored.
Intestinal GVHD was evaluated by crypt apoptosis bodies per 10 crypts.
Cytokine levels were analyzed from serum samples obtained from heart
puncture after 5 days post-transplantation. To measure the cytokines granulo-
cyte-macrophage colony stimulating factor, IL-2, IL-4, IL-5, IL-10, IL-12p70,
IL-17A, IL-23, TNF-a, and IFN-g, we used the mouse MACSPlex Cytokine 10 kit
(Miltenyi Biotec) according to the manufacturer’s instructions and then acquired
them in a FACSCanto II flow cytometer (BD Biosciences, Franklin Lakes, NJ). The
analysis was performed with FCAP Array Analysis Software (BD Biosciences).
The quantity of butyrate in feces was determined in the mice on the day
before they started the PE diet and 14 days after transplantation. Approximately
400 mg of thawed feces was homogenized with 1.8 mL milli-Q water. Then,
0.4 mL H2SO4 (50%) was added, and themixture was vortexed for 2 minutes.
Then, 0.8 g NaCl, 1 mL diethyl ether, and 20 mL internal butyrate standard
(100-mM solution of butyric acid-d8 in methanol) were added, and the mixture
was vortexed again. The phases were separated by orbital shaking for 1 hour
and centrifugation at 3000 rpm for 5 minutes at room temperature. The supe-
rior phase was recovered and injected in a Shimadzu GCMS-QP2010 Ultra Stan-
dard Gas Chromatograph-Mass Spectrometer (Shimadzu, Kyoto, Japan).
The concentrations, expressed in nmol of butyrate per gram of faces,
were calculated using the linear regression equations obtained for the corre-
sponding standard curves, which were obtained using 10 different concen-
trations of butyrate.
Figure 1. Effect of olive oil polyphenols on T cell viability, activation, and proliferation. Peripheral blood mononuclear cells were stimulated in the presence of differ-
ent concentrations of PE. (A) Dot plot flow cytometry analysis of Annexin V/7AAD and percentage of viable cells. (B) Dot plot image and percentage of T cell activation
(CD3+/CD25+) stimulated with anti-CD3 plus anti-CD28 and cultured in the presence of PE (10, 45, and 60 mg/mL). (C) T cell proliferation assessed by PKH-67 dilution
of unstimulated or stimulated T cells cultured with PE (10, 45, and 60 mg/mL). (D) Percentage of CD64 cells among CD4+ and CD8+ T cells unstimulated or stimulated
in the presence of different concentrations of PE. Data are represented by the mean § SME of 4 to 6 independent experiments. *P < .05. *** P < .001. ****P < .0001.
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Figure 2. Effect of PE on T cell cytokine secretion. The concentration of IL-2, IFN-g, TNF-a, IL-4, IL-6, and IL-10 in the culture supernatant of PBMCs stimulated in the
presence of different concentrations PE (10, 45, and 60 mg/mL) is shown. Data are represented by the mean § SEM of 3 independent experiments. *P < .05, ** P < .01
(with respect to the stimulated untreated sample).
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Most statistical analyses were performed using IBM SPSS Statistics
19 software (SPSS, Inc., Chicago, IL). Statistical significance was assessed byFigure 3. Western blot analysis of p-Akt protein phosphorylation (A) and NF-
kB expression (C) in stimulated peripheral blood mononuclear cells for
18 hours with anti-CD3 and anti-CD28 mABs, in the presence of different con-
centrations of PE (10, 45, and 60 mg/mL). Representative image of 3 indepen-
dent experiments.the Student t test or 1-way analysis of variance (ANOVA) test. Pairwise
comparisons were performed using the Mann-Whitney test with Bonferroni
correction.
A 2-way measurement of repeated multiple ANOVA (2-way ANOVA) was
performed to analyze the signs of GVHD at different times, and survival
curves were plotted using Kaplan-Meier estimates, and a log-rank test was
used to compare survival rates. Statistical significance in all tests was defined
as P < .05. All graphics were done using the PRISM software package (Graph-
Pad Software, La Jolla, CA).RESULTS
Chemical Composition of PE from EVOO
Phenolic content of PE determined by 1H NMR (proton
nuclear magnetic resonance) spectroscopy was performed.
The 2 most common phenolic compounds were hydroxytyro-
sol (36.49 mmol/100 g) and tyrosol (30.32 mmol/100 g).Effect of Olive Oil PE on T Cell Activation, Proliferation, and
Apoptosis Induction
First, the effect of PE obtained from EVOO on the viability
and activation in stimulated T cells was assessed. We
observed no effect on T cell viability (Figure 1A) when we
added PE to the cultures. By contrast, PE decreased the acti-
vation of stimulated T-lymphocytes, as shown in Figure 1B,
and reduced cell proliferation (Figure 1C). The expression of
CD64, a classical early marker of lymphocyte activation, was
also evaluated in the different CD4+ and CD8+ T cells unsti-
mulated or stimulated with CD3/CD28. The effect of the PE
on these subpopulations was similar to what observed with
CD25 (Figure 1D).
Figure 4. Cytotoxic effect of T cells against murine leukemic cells treated with PE. (A, B) Flow cytometry of isolated T cells from the spleen of BALB/C mice cocultured
with A20 (n = 4) and C1498 (n = 4) at a ratio of 1:3 and 1:5, with or without PE (10 mg/mL). Right panels show the percentage of Annexin V and 7AAD+ cells among
CD4+ and CD8+ T cells. (C, D) Flow cytometry of isolated T cells from the spleen of C57BL/6 (B6) mice cocultured with A20 (n = 4) and C1498 (n = 4) at a ratio of 1:3
and 1:5, with or without PE (10 mg/mL), and percentage of Annexin V and 7AAD+ cells among CD4+ and CD8+ T cells. Data are represented by the mean § SEM. *P <
.05, ** P < .01 (with respect to A20 and C1498).
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PE induced a dose-dependent decrease in Th1 (IFN-g, IL-2,
and TNF-a)/Th2 (IL-4, IL-6, and IL-10) cytokine secretion in
vitro. At a concentration of 10 mg/mL, PE induced a significant
decrease in TNF-a and IL-2 secretion (Figure 2).PE Reduces the Expression of Proteins Related to
Proliferation and Survival
Western blot assays were performed to identify pathways
involved in T cell survival and proliferation affected by expo-
sure to PE. PE reduced AKT phosphorylation and nuclear
Figure 5. Acute GVHDmurine models. (A) Percentage of body weight loss (P  .05 between days +21 and +45 after transplantation) of mice transplanted with 5 £ 106
bone marrow cells and 5£ 106 splenocytes receiving a standard diet or a standard diet supplemented with 600 ppm PE obtained from EVOO. (B) Median aGVHD score
of transplanted mice that received a control diet or a PE diet (P .05 for day 37 post-transplantation). (C) Kaplan-Meier curve representing overall survival of different
experimental groups: total body irradiation (TBI; n = 2), BM-transplanted group that received the standard diet (n = 2), BM-transplanted group that received the stan-
dard diet supplemented with 600 ppm PE obtained from EVOO (n = 2), GVHD group that received the standard diet (n = 18), and GVHD group that received the stan-
dard diet supplemented with 600 ppm PE obtained from EVOO (n = 20). Combined data from 2 to 3 (n = 4 to 5 mice for each experiment group) experiments are
shown.
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tion with a concentration superior to 45 mg/mL (Figure 3A,B).Effect of T Cells against Murine Leukemic Cells
Once we confirmed that PE was able to decrease T cell acti-
vation and proinflammatory cytokine secretion, we next stud-
ied the effect of T cells exposed to PE on tumor viability by
flow cytometry using 7AAD and Annexin V staining. In the
presence of T cells from BALB/C and C57BL/6 mice, the viability
of A20 and C1498 leukemic cells significantly decreased
(Figure 4). Remarkably, this effect did not change in the pres-
ence of PE (10 mg/mL).
Next, we evaluated ex vivo lymphocyte cytotoxic activity in
the presence of PE. After 48 hours in the presence of different
concentrations of PE, the splenocytes from BALB/C and C57BL/
6 mice (with and without the presence of stimulation) were
cocultured with 2 different murine leukemic cells for 24 hours.
As shown in the Supplementary Figure S1, the splenocytes
were able to maintain a significant cytotoxic activity againstleukemic cells. Accordingly, a decrease of C1498 and A20 cell
viability was observed after coculture with T cells that were
previously treated with different concentrations of PE.Treatment of Mice with PE Improves Survival and Clinical
Stage of the aGVHDMurine Model
To examine the efficacy of a diet rich in PE from EVOO to
improve survival and decrease the risk of aGVHD in vivo, we
used a GVHD murine model.
As shown in Figure 5, mice receiving a supplemented diet
had a significantly lower score (P .05 after day 37 post-trans-
plantation) and a significantly lower weight loss between days
+21 and +45 after transplantation (P  .05) (Figure 5A,B), as
well as a significantly increased survival as compared with the
mice that received a standard diet (Figure 5C).
We next quantified 10 different cytokines (granulocyte-
macrophage colony stimulating factor, IFN-g, IL-2, IL-4, IL-5,
IL-10, IL-12p70, IL-17A, IL-23, and TNF-a) from the plasma of
mice that received a standard or supplemented diet on day 5
Figure 6. Determination of cytokine concentrations (IFN-g, IL-2, IL-4, IL-5, IL-10, IL-12p70, IL-17, and TNF-a) in the plasma of mice that underwent transplantation
with 5 £ 106 bone marrow cells and 5 £ 106 splenocytes receiving a standard diet or a standard diet supplemented with 600 ppm PE obtained from EVOO 5 days after
transplantation. Data are represented as the median of 4 to 7 serum mice/group from 2 independent experiments. *P ˂ .05 (Mann-Whitney test).
Figure 7. Butyrate feces analysis. The concentration of butyrate in the feces of
animals before transplant (day 6; n = 6) and 14 days post-transplantation
among mice receiving a standard diet (n = 5) or a standard diet supplemented
with 600 ppm PE obtained from EVOO (n = 9). Data are represented by the
mean § SEM. *P< .05.
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concentration of proinflammatory cytokines, including IL-2
(P = .0253), IL-17 (P = .0365), and TNF-a (P = .0209), among the
mice receiving the supplemented diet (Figure 6).
We determined the concentration of butyrate in the feces
of the different mice groups on day 6 before transplant and
14 days post-transplantation. We observed that the group that
received the PE-enriched diet recovered the concentration of
butyrate in the feces (Figure 7).To evaluate aGVHD target organs, histologic analysis of
skin and intestine was performed on days 5 and 21 after
transplantation.
The skin of both subgroups displayed pathologic findings of
aGVHD, including hyperkeratosis, focal hypergranulosis, focal
vacuolization, and presence of apoptotic bodies in the basal
layer of the epidermis as well as a focal inflammatory infiltrate
in the dermis (Figure 8). Despite no significant differences
between subgroups in the skin, the control diet group dis-
played a significantly worse GVHD score between days 5 and
21 post-transplantation.
By contrast, when we analyzed the intestine, we observed
significant differences between the 2 groups regarding the
number of apoptotic bodies per 10 crypts on days 5 and 21
after transplantation (Figure 9). The intestine of the control
group showed a median of 10.25 apoptotic bodies for every 10
crypts as compared with 4.25 apoptotic bodies for every 10
crypts in animals that received the supplemented diet 5 days
post-transplantation (Figure 9A). After 21 days, significant dif-
ferences in the number of apoptotic bodies again were
observed upon comparing the group receiving the PE-supple-
mented diet versus the control group diet (Figure 9B). More-
over, the previous group had a moderate and the latter a mild
focal inflammatory infiltrate. When we compared the histo-
logic score in the intestine, significant differences between the
control diet and PE diet on day 5 after transplantation were
observed (Figure 9C).
In addition, we analyzed the expression of CD3, Ki67
(proliferation marker), and IFN-g in mice colon and small
Figure 8. Histopathologic skin analysis of aGVHD mouse model. Photomicrographs in hematoxylin and eosinstained sections of skin samples collected on day 5 (A)
and 21 (B) after transplantation. Magnification is indicated in each photomicrograph. (C) Data of histologic GVHD score (single blind evaluation, n = 4/ group, data
pooled from 1 experiment). Data are represented by the mean § SEM. *P < .05.
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Supplementary Figure S2 (small intestine) and Supplementary
Figure S3 (large intestine), proliferating CD3 T cells (CD3+Ki67+)
were significantly increased in the control group. The presence
of IFN-g+ T cells was also increased in the samples from the small
and large intestine from the control group. This is in contrast to
the data observed in bone marrow, lymph nodes, and spleen
where no significant differences were observed in terms of T cell
activation or proliferation between both groups (data not
shown).
DISCUSSION
After allogeneic transplantation [1], GVHD is the most dev-
astating complication hampering the success of the procedure.
It is mainly due to the activation of alloreactive T cells, which
induce cytotoxic damage in normal host tissues [3]. Prevention
strategies for the reduction of GVHD are based on the combi-
nation of calcineurin [21] inhibitors plus methotrexate or
mycophenolate mofetil, among other options; however, with
these standard approaches, the risk of acute and chronic
GVHD ranges between 25% and 70% among patients receiving
transplantation from a sibling donor.
In the current study, we have evaluated the immunomodu-
latory effect of the EVOO PE in the prophylaxis of aGVHD. Wehave demonstrated that PE present in EVOO reduces T cell acti-
vation and proliferation in vitro. These results are in accor-
dance with previous studies showing that PE decreased IFN-g
production by stimulated T cells. More specifically, Zou et al.
[22] described that resveratrol inhibits T cell activation
through the Sirt1 protein. The inhibitory effect of apigenin on
T cell activation has also been described in response to conca-
navalin A [23].
In addition, we have found that PE decreases pAKT in stim-
ulated T-lymphocytes. This is in agreement with previous
studies showing that EGCG, a compound found in green tea,
inhibits the PI3K/AKT pathway by decreasing the levels of the
p85 and p110 subunits of PI3K and the levels of P-AKT [24].
Furthermore, curcumin treatment inhibits AKT phosphoryla-
tion in different cancer cell types [25].
In the current study, cytokine secretion assays confirmed
that PE reduced Th1 and Th2 cytokine secretion by stimulated
T cells. Activation and proliferation of T-lymphocytes result in
an increased transcription of cytokine genes and their recep-
tors, thus producing a massive release of proinflammatory
mediators (TNF-a, IL-1, IFN-g) that cause tissue damage.
Accordingly, the number of T-lymphocytes producing IL-2 has
been related to the severity of GVHD. In a murine model of
aGVHD, we have verified that those animals receiving a
Figure 9. Histopathologic gut analysis of aGVHD mouse model. Photomicrographs in hematoxylin and eosinstained sections of intestine samples collected on day 5
(A) and 21 (B) after transplantation. Magnification is indicated in each photomicrograph. The quantification of apoptotic bodies per 10 crypts in an aGVHD mouse
model. Intestine samples, frommice receiving standard diet and standard diet supplemented with PE, collected on days 5 and 21 after transplantation. (C) Data of his-
tologic GVHD score (single blind evaluation, n = 4/ group, data pooled from 1 experiment). Data are represented by the mean § SEM. *P< .05. **P < .01. ***P < .001.
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tory cytokines, with significant differences for IL-2, IL-17, and
TNF-g at 5 days post-transplant, compared with animals
receiving a control diet. In this regard, Aparicio-Soto et al. [26]
demonstrated that an EVOO-rich diet significantly reduced the
production of TNF-a, IL-6, IL-10, and IL-17 in lipopolysaccha-
ride-stimulated splenocytes from lupus-induced mice as com-
pared with those animals that were fed with a standard diet.
Interestingly, it has been described that oleuropein glucoside
decreases the production of IL-1b [27]. Moreover, a clinical
trial in patients with coronary heart disease showed that the
consumption of EVOO enriched in PE was associated with a
decreased production of IL-6 and lower levels of C-reactive
protein [28]. All these studies support the idea that PEs modu-
late the immune response and have potent anti-inflammatory
activity.
Finally, we have demonstrated that the use of a diet enriched
in PE from EVOO decreases the occurrence of aGVHD in amurine
model. The use of a diet supplemented with PE significantly
improved mice survival and ameliorated aGVHD clinical signs. It
has been described that some chemical derivatives of plants can
reduce the severity of GVHD and graft rejections [29]. This was
the case for PG27 extracted from Tripterygium wilfordii, which
reduced GVHD in a murine model of allogeneic bone marrow
transplantation [30]. Kanamune et al. [31] showed that EGCG
inhibited the activation of T-lymphocytes in vitro, and in a
murine model, splenocytes treated with this polyphenol were
less potent in inducing GVHD. Subsequently, Choi et al. [32]
evaluated the use of EGCG by intraperitoneal administration in
different GVHD animal models without obtaining improvement
in survival or weight reduction. However, a recent study showed
that EGCG ameliorated aGVHD and reduced GVHD-related
target organ damage by increasing regulatory T cell number
and reducing oxidative stress [33]. In the current study,histopathologic analysis showed that animals that received the
supplemented diet had fewer apoptotic bodies in the crypts as
compared with those that did not receive PE. However, no sig-
nificant differences were observed in skin, which suggests a local
effect in gastrointestinal mucosa. Moreover, we did not observe
significant differences in T cell activation or proliferation or in
Treg numbers in the bone marrow, blood, and spleen of mice
receiving or not the EVOO-supplemented diet. Accordingly, our
data suggest that this diet has a local effect in the gut without
modifying the immune response systemically. Considering the
main role of the gut in the pathophysiology of GVHD, mainly
through cytokine secretion, this local effect could finally lead
to a lower systemic GVHD score while maintaining a graft-
versus-leukemia effect. Although further in vivo studies will be
required to confirm this aspect, in vitro assays do confirm that
EVOO does not hamper the cytotoxic effect of T cells on leukemic
cells.
Different studies have shown that patients with GVHD
present an altered intestinal microbiota that correlates with
GVHD severity [34]. These changes in the microbiota result in
alterations in the levels of microbial metabolites such as short-
chain fatty acids. A recent report showed that butyrate, a
short-chain fatty acid derived from microbiota, which is a pre-
ferred energy source for intestinal epithelial cells (IECs), signif-
icantly decreases after allo-HSCT [35]. Mathewson et al. [35]
showed that a decreased amount of butyrate in CD326+IECs
results in decreased histone acetylation, which is restored
upon administration of exogenous butyrate. Butyrate restora-
tion also improved IEC junctional integrity, decreased apopto-
sis, and mitigated GVHD. In our study, we demonstrated a
significant decrease in the concentration of butyrate in feces
of mice that developed aGVHD and a restoration of butyrate
levels in mice receiving a diet supplemented in PE from
EVOO. Interestingly, different studies have shown that the
624 I. Alvarez-Laderas et al. / Biol Blood Marrow Transplant 26 (2020) 615624supplementation with PE might select butyrate-producing
bacteria (such as Clostridiaceae) and improve gut bacterial
abundance [36]. Our data do not directly address the changes
in the amount of butyrate-producing bacteria and the effects
of GVHD protection. However, a growing body of evidence
indicates that we can change the GVHD pathophysiology in
not only suppressing the donor immune system but also
manipulating the host response to injury. Considering the crit-
ical role of the gastrointestinal tract on the pathophysiology of
GVHD, these data represent a significant finding in the current
study.
In summary, PEs obtained from EVOO are immunomodula-
tory agents, being able to decrease T cell activation and prolif-
eration in cell culture and inhibiting the production of
proinflammatory cytokines. In addition, its use as a dietary
supplement in a murine model of aGVHD increases the sur-
vival of mice and decreases the severity of the disease, mainly
in the digestive tract.
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